| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase binding | DAB2IP SPDYE17 SPDYE10 PPP1R12A PPP1R12B TRIM68 SPDYE11 CDK5RAP3 SPDYE15 PTPRK SPDYE8 KIF14 PLD2 CDH1 NBR1 SPDYE14 DNM2 | 7.02e-05 | 873 | 133 | 17 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | DAB2IP SPDYE17 PDE8A SPDYE10 PPP1R12A PPP1R12B TRIM68 SPDYE11 CDK5RAP3 SPDYE15 PTPRK SPDYE8 KIF14 PLD2 CDH1 NBR1 SPDYE14 DNM2 | 7.74e-05 | 969 | 133 | 18 | GO:0019900 |
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 TBC1D9B PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PLCD4 PCDHA6 TBC1D9 PRRG3 CDH1 PCDHGC3 PCDH8 | 1.42e-04 | 749 | 133 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | CFTR RNF213 CHD8 ATP9B FANCM DHX15 ENTPD1 KIF14 DNA2 DNAH5 DNAH8 | 1.81e-04 | 441 | 133 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO7B CFTR RNF213 CHD8 ATP9B FANCM DHX15 MOCS3 ENTPD1 KIF14 DNA2 DNAH5 DNAH8 | 2.36e-04 | 614 | 133 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | enzyme regulator activity | DAB2IP TBC1D9B PDE8A PPP1R12A PPP1R12B MCF2L2 ARFGEF2 PLCD4 APOA4 SHOC2 CARD8 TBC1D9 ITIH5 PLEKHG4B PPP2R1B THADA C3 ARHGAP27 GNAZ DOCK6 RASAL2 | 4.45e-04 | 1418 | 133 | 21 | GO:0030234 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT4 PCDHGB3 TRO FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 PLXNB2 CDH1 PCDHGC3 PCDH8 | 1.16e-10 | 187 | 125 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHGB3 TRO FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 PLXNB2 ARVCF CDH1 PCDHGC3 PCDH8 | 6.94e-09 | 313 | 125 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 7.98e-07 | 53 | 125 | 6 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FAT4 PCDHGB3 TRO FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 APOA4 PRDX2 PLXNB2 PLEKHG4B NLGN3 ARVCF ENTPD1 PLEKHA7 CDH1 PCDHGC3 PCDH8 | 7.32e-06 | 1077 | 125 | 20 | GO:0098609 |
| GeneOntologyCellularComponent | AIP1-IRE1 complex | 3.60e-05 | 2 | 126 | 2 | GO:1990597 | |
| Domain | CA | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 FREM2 CDH1 PCDHGC3 PCDH8 | 1.63e-11 | 115 | 125 | 12 | SM00112 |
| Domain | Cadherin | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 FREM2 CDH1 PCDHGC3 PCDH8 | 2.21e-11 | 118 | 125 | 12 | IPR002126 |
| Domain | Cadherin_CS | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 CDH1 PCDHGC3 PCDH8 | 1.70e-10 | 109 | 125 | 11 | IPR020894 |
| Domain | CADHERIN_1 | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 CDH1 PCDHGC3 PCDH8 | 2.52e-10 | 113 | 125 | 11 | PS00232 |
| Domain | Cadherin | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 CDH1 PCDHGC3 PCDH8 | 2.52e-10 | 113 | 125 | 11 | PF00028 |
| Domain | CADHERIN_2 | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 CDH1 PCDHGC3 PCDH8 | 2.78e-10 | 114 | 125 | 11 | PS50268 |
| Domain | - | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 CDH1 PCDHGC3 PCDH8 | 2.78e-10 | 114 | 125 | 11 | 2.60.40.60 |
| Domain | Cadherin-like | FAT4 PCDHGB3 FAT3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 CDH1 PCDHGC3 PCDH8 | 3.35e-10 | 116 | 125 | 11 | IPR015919 |
| Domain | Cadherin_2 | 1.18e-08 | 65 | 125 | 8 | PF08266 | |
| Domain | Cadherin_N | 1.18e-08 | 65 | 125 | 8 | IPR013164 | |
| Domain | Cadherin_C | 3.43e-07 | 42 | 125 | 6 | IPR032455 | |
| Domain | Cadherin_C_2 | 3.43e-07 | 42 | 125 | 6 | PF16492 | |
| Domain | - | DAB2IP MYO7B MCF2L2 PLCD4 PLEKHG4B OSBPL7 GAB3 PLD2 ARHGAP27 PLEKHA7 TNS1 RASAL2 DNM2 | 2.24e-06 | 391 | 125 | 13 | 2.30.29.30 |
| Domain | PH | DAB2IP MCF2L2 PLCD4 PLEKHG4B OSBPL7 GAB3 PLD2 ARHGAP27 PLEKHA7 RASAL2 DNM2 | 2.70e-06 | 278 | 125 | 11 | SM00233 |
| Domain | PH_DOMAIN | DAB2IP MCF2L2 PLCD4 PLEKHG4B OSBPL7 GAB3 PLD2 ARHGAP27 PLEKHA7 RASAL2 DNM2 | 2.79e-06 | 279 | 125 | 11 | PS50003 |
| Domain | PH_domain | DAB2IP MCF2L2 PLCD4 PLEKHG4B OSBPL7 GAB3 PLD2 ARHGAP27 PLEKHA7 RASAL2 DNM2 | 2.89e-06 | 280 | 125 | 11 | IPR001849 |
| Domain | PH_dom-like | DAB2IP MYO7B MCF2L2 PLCD4 PLEKHG4B OSBPL7 GAB3 PLD2 ARHGAP27 PLEKHA7 TNS1 RASAL2 DNM2 | 5.70e-06 | 426 | 125 | 13 | IPR011993 |
| Domain | PDEase_PDE8 | 4.44e-05 | 2 | 125 | 2 | IPR013938 | |
| Domain | DUF3498 | 1.33e-04 | 3 | 125 | 2 | IPR021887 | |
| Domain | PRKG1_interact | 1.33e-04 | 3 | 125 | 2 | IPR031775 | |
| Domain | PRKG1_interact | 1.33e-04 | 3 | 125 | 2 | PF15898 | |
| Domain | MYPT1/MYPT2_chordates | 1.33e-04 | 3 | 125 | 2 | IPR017401 | |
| Domain | DUF3498 | 1.33e-04 | 3 | 125 | 2 | PF12004 | |
| Domain | - | 1.54e-04 | 16 | 125 | 3 | 1.10.506.10 | |
| Domain | RasGAP_dom | 2.22e-04 | 18 | 125 | 3 | IPR001936 | |
| Domain | ThyrH_rcpt | 4.39e-04 | 5 | 125 | 2 | IPR001728 | |
| Domain | ARM-type_fold | 4.65e-04 | 339 | 125 | 9 | IPR016024 | |
| Domain | PUB_domain | 6.55e-04 | 6 | 125 | 2 | IPR018997 | |
| Domain | Ig_E-set | 6.72e-04 | 104 | 125 | 5 | IPR014756 | |
| Domain | PH | 8.91e-04 | 229 | 125 | 7 | PF00169 | |
| Domain | DHC_N1 | 1.21e-03 | 8 | 125 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.21e-03 | 8 | 125 | 2 | IPR013594 | |
| Domain | - | MYO7B CFTR RNF213 CHD8 FANCM TEP1 DHX15 GNAZ DNA2 HS3ST1 DNAH5 DNAH8 DNM2 | 1.48e-03 | 746 | 125 | 13 | 3.40.50.300 |
| Domain | P-loop_NTPase | MYO7B CFTR RNF213 CHD8 FANCM TEP1 DHX15 KIF14 GNAZ DNA2 HS3ST1 DNAH5 DNAH8 DNM2 | 1.62e-03 | 848 | 125 | 14 | IPR027417 |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.64e-03 | 35 | 125 | 3 | IPR002464 | |
| Domain | Cadherin_tail | 1.93e-03 | 37 | 125 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 1.93e-03 | 37 | 125 | 3 | IPR031904 | |
| Domain | DEAH_ATP_HELICASE | 2.08e-03 | 38 | 125 | 3 | PS00690 | |
| Domain | GBD/FH3_dom | 2.35e-03 | 11 | 125 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 2.35e-03 | 11 | 125 | 2 | PS51232 | |
| Domain | AAA | 2.84e-03 | 144 | 125 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 2.84e-03 | 144 | 125 | 5 | IPR003593 | |
| Domain | Rho_GTPase_activation_prot | 2.89e-03 | 88 | 125 | 4 | IPR008936 | |
| Domain | - | 3.83e-03 | 222 | 125 | 6 | 1.25.10.10 | |
| Domain | RasGAP | 3.84e-03 | 14 | 125 | 2 | SM00323 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.84e-03 | 14 | 125 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.84e-03 | 14 | 125 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.84e-03 | 14 | 125 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.84e-03 | 14 | 125 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.84e-03 | 14 | 125 | 2 | IPR011704 | |
| Domain | MT | 3.84e-03 | 14 | 125 | 2 | PF12777 | |
| Domain | AAA_8 | 3.84e-03 | 14 | 125 | 2 | PF12780 | |
| Domain | RasGAP_CS | 3.84e-03 | 14 | 125 | 2 | IPR023152 | |
| Domain | AAA_5 | 3.84e-03 | 14 | 125 | 2 | PF07728 | |
| Domain | DHC_fam | 4.41e-03 | 15 | 125 | 2 | IPR026983 | |
| Domain | RasGAP | 4.41e-03 | 15 | 125 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.41e-03 | 15 | 125 | 2 | PS00509 | |
| Domain | FH2 | 4.41e-03 | 15 | 125 | 2 | PS51444 | |
| Domain | Dynein_heavy | 4.41e-03 | 15 | 125 | 2 | PF03028 | |
| Domain | FH2_Formin | 4.41e-03 | 15 | 125 | 2 | IPR015425 | |
| Domain | FH2 | 4.41e-03 | 15 | 125 | 2 | PF02181 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.41e-03 | 15 | 125 | 2 | PS50018 | |
| Domain | Dynein_heavy_dom | 4.41e-03 | 15 | 125 | 2 | IPR004273 | |
| Domain | FH2 | 4.41e-03 | 15 | 125 | 2 | SM00498 | |
| Domain | GRAM | 5.01e-03 | 16 | 125 | 2 | SM00568 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGB3 PCDHB13 PCDHB12 PCDHB11 PCDHB4 PCDHA6 CDH1 PCDHGC3 PCDH8 | 1.36e-11 | 74 | 135 | 9 | 10817752 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.54e-10 | 68 | 135 | 8 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 4.06e-10 | 72 | 135 | 8 | 10380929 | |
| Pubmed | 7.02e-10 | 77 | 135 | 8 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 9.58e-10 | 80 | 135 | 8 | 10716726 | |
| Pubmed | 4.87e-09 | 17 | 135 | 5 | 18279309 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 9.43e-08 | 57 | 135 | 6 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.05e-07 | 58 | 135 | 6 | 30377227 | |
| Pubmed | 1.51e-07 | 13 | 135 | 4 | 12231349 | ||
| Pubmed | DAB2IP PPP1R12A CHD8 PRDX2 RTN1 NLGN3 AKAP9 ARVCF PI4KA TNKS SSH2 TNS1 NOS1 PCDH8 KDM1A RASAL2 DNM2 | 2.18e-07 | 963 | 135 | 17 | 28671696 | |
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 31883643 | ||
| Pubmed | DAB2IP CCDC22 CEP85 PPP1R12B RNF213 PSMD11 SHOC2 AKAP9 PTPRK ARVCF PI4KA NUP210 KIF14 SSH2 PLEKHA7 TNS1 NBR1 | 7.13e-07 | 1049 | 135 | 17 | 27880917 | |
| Pubmed | 1.00e-06 | 20 | 135 | 4 | 11322959 | ||
| Pubmed | 2.04e-06 | 214 | 135 | 8 | 22199357 | ||
| Pubmed | 3.04e-06 | 26 | 135 | 4 | 21303848 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PPP1R12A SAMD4B RNF213 ATP9B FRYL INTS3 TEP1 PLEKHG4B NLGN3 PPP2R1B EXD3 THADA THRA THRB ENTPD1 NUP210 GNAZ DOCK6 NBR1 | 5.15e-06 | 1489 | 135 | 19 | 28611215 |
| Pubmed | 6.73e-06 | 10 | 135 | 3 | 22969705 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TBC1D9B PPP1R12A CFTR PSMD11 PRDX2 PPP2R1B THADA NUP210 C3 PLEC CDH1 DNM2 | 8.97e-06 | 647 | 135 | 12 | 26618866 |
| Pubmed | Loss-of-function mutations in FREM2 disrupt eye morphogenesis. | 9.22e-06 | 11 | 135 | 3 | 30802441 | |
| Pubmed | CEP85 SAMD4B FRYL AKAP9 KIF14 CEP295 DOCK6 PLEKHA7 FMNL1 RASAL2 | 1.03e-05 | 446 | 135 | 10 | 24255178 | |
| Pubmed | PPP1R12A PPP1R12B ARFGEF2 PRDX2 RTN1 DHX15 NLGN3 ARVCF PI4KA SSH2 UQCRFS1 PLEC GNAZ PLEKHA7 TNS1 NOS1 RASAL2 DNM2 | 1.13e-05 | 1431 | 135 | 18 | 37142655 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 14760158 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11861164 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 22570333 | ||
| Pubmed | cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis. | 1.50e-05 | 2 | 135 | 2 | 22232524 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 10430610 | ||
| Pubmed | Audiogenic seizure susceptibility in thyroid hormone receptor beta-deficient mice. | 1.50e-05 | 2 | 135 | 2 | 11496110 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26672044 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21622534 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 10346821 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9861043 | ||
| Pubmed | Kinases, myosin phosphatase and Rho proteins: curiouser and curiouser. | 1.50e-05 | 2 | 135 | 2 | 10200412 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 38889231 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11739587 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 21187369 | ||
| Pubmed | Impaired hair growth and wound healing in mice lacking thyroid hormone receptors. | 1.50e-05 | 2 | 135 | 2 | 25254665 | |
| Pubmed | Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism. | 1.50e-05 | 2 | 135 | 2 | 19282388 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20141582 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12750454 | ||
| Pubmed | Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. | 1.50e-05 | 2 | 135 | 2 | 27974415 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 38757582 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 28911178 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11222741 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 16781732 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17911173 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 10848522 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15780976 | ||
| Pubmed | Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. | 1.50e-05 | 2 | 135 | 2 | 12933686 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24797634 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11726557 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 10691312 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18203951 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19853653 | ||
| Pubmed | New Insights into the Structure and Function of the Thyroid Hormone Receptor. | 1.50e-05 | 2 | 135 | 2 | 11725045 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20194731 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11113349 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18287507 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24325866 | ||
| Pubmed | Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. | 1.50e-05 | 2 | 135 | 2 | 12356724 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9250685 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12198244 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12562961 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 2879243 | ||
| Pubmed | Distinct behavioral phenotypes in male mice lacking the thyroid hormone receptor α1 or β isoforms. | 1.50e-05 | 2 | 135 | 2 | 23567476 | |
| Pubmed | Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis. | 1.50e-05 | 2 | 135 | 2 | 19549593 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12681444 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 29753845 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 15466465 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 10712278 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 36277728 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 12776178 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 24673558 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 37992217 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23493375 | ||
| Pubmed | Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1. | 1.50e-05 | 2 | 135 | 2 | 15858214 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20090848 | ||
| Pubmed | Phosphodiesterase 8A Regulates CFTR Activity in Airway Epithelial Cells. | 1.50e-05 | 2 | 135 | 2 | 34936285 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 9927422 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20062085 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 17932484 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19094093 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11120878 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11867729 | ||
| Pubmed | Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. | 1.50e-05 | 2 | 135 | 2 | 19131509 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 20736347 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 10362681 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 11481455 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 23300972 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26715425 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19903799 | ||
| Pubmed | Cardiac glucose utilization in mice with mutated alpha- and beta-thyroid hormone receptors. | 1.50e-05 | 2 | 135 | 2 | 15304375 | |
| Pubmed | Functionally impaired TR mutants are present in thyroid papillary cancer. | 1.50e-05 | 2 | 135 | 2 | 11889175 | |
| Pubmed | Distribution of the nuclear thyroid-hormone receptor in extraocular and skeletal muscles. | 1.50e-05 | 2 | 135 | 2 | 1517709 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 16051666 | ||
| Pubmed | The thyroid hormone receptors as modulators of skin proliferation and inflammation. | 1.50e-05 | 2 | 135 | 2 | 21566120 | |
| Pubmed | Dynamin-2 is a novel NOS1β interacting protein and negative regulator in the collecting duct. | 1.50e-05 | 2 | 135 | 2 | 26791826 | |
| Pubmed | Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo. | 1.50e-05 | 2 | 135 | 2 | 29229863 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 18844476 | ||
| Pubmed | Gaining ligand selectivity in thyroid hormone receptors via entropy. | 1.50e-05 | 2 | 135 | 2 | 19926848 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 26451739 | ||
| Interaction | CLEC4A interactions | DAB2IP PCDHB13 ARFGEF2 RNF213 THADA PTPRK LRRN2 CDH1 PCDHGC3 | 1.92e-08 | 103 | 128 | 9 | int:CLEC4A |
| Interaction | KRT8 interactions | CCDC22 CEP85 RNF31 CFTR NUP88 THADA THRB AKAP9 KRT75 KIF14 PLEC CDH1 NBR1 CLUH | 8.44e-07 | 441 | 128 | 14 | int:KRT8 |
| Interaction | ZBBX interactions | 1.42e-06 | 31 | 128 | 5 | int:ZBBX | |
| Interaction | KRT19 interactions | CCDC22 CEP85 RNF31 CFTR PCDHB12 NUP88 AKAP9 KRT75 CEP295 PLEC KDM1A | 1.90e-06 | 282 | 128 | 11 | int:KRT19 |
| Interaction | XAGE1A interactions | 5.96e-06 | 41 | 128 | 5 | int:XAGE1A | |
| Interaction | SIGLECL1 interactions | 7.81e-06 | 113 | 128 | 7 | int:SIGLECL1 | |
| Interaction | LGALS1 interactions | FAT4 FAT3 CFTR PLXNB2 NLGN3 FREM2 PTPRK KIF14 UQCRFS1 NBR1 CLUH | 9.01e-06 | 332 | 128 | 11 | int:LGALS1 |
| Interaction | CD160 interactions | 1.31e-05 | 48 | 128 | 5 | int:CD160 | |
| Interaction | C19orf38 interactions | 1.81e-05 | 86 | 128 | 6 | int:C19orf38 | |
| Interaction | CARD16 interactions | 2.04e-05 | 9 | 128 | 3 | int:CARD16 | |
| Interaction | SYNE3 interactions | CEP85 SAMD4B NUP88 GXYLT1 RTN1 NUP210 KIF14 CEP295 PLEC PLEKHA7 NBR1 CLUH | 2.67e-05 | 444 | 128 | 12 | int:SYNE3 |
| Interaction | TBC1D8B interactions | 3.98e-05 | 11 | 128 | 3 | int:TBC1D8B | |
| Interaction | CTAG2 interactions | 6.98e-05 | 35 | 128 | 4 | int:CTAG2 | |
| Interaction | DAAM1 interactions | 9.51e-05 | 72 | 128 | 5 | int:DAAM1 | |
| Interaction | PLEC interactions | CFTR NUP88 FANCM THRB KIF14 PLEC DNA2 CDH1 DNAH5 FMNL1 KDM1A | 9.54e-05 | 430 | 128 | 11 | int:PLEC |
| Cytoband | 5q31 | 5.75e-08 | 115 | 136 | 7 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 1.63e-06 | 271 | 136 | 8 | chr7q11 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 3.23e-05 | 298 | 136 | 7 | chr5q31 | |
| Cytoband | 7q11.23 | 2.06e-04 | 97 | 136 | 4 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 5.50e-04 | 473 | 136 | 7 | chr17q21 | |
| Cytoband | 4q28.1 | 1.02e-03 | 16 | 136 | 2 | 4q28.1 | |
| GeneFamily | Clustered protocadherins | 5.34e-08 | 64 | 98 | 7 | 20 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.30e-04 | 206 | 98 | 7 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.27e-03 | 10 | 98 | 2 | 830 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.63e-03 | 43 | 98 | 3 | 409 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 1.85e-03 | 12 | 98 | 2 | 756 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 2.18e-03 | 13 | 98 | 2 | 1146 | |
| GeneFamily | Dyneins, axonemal | 3.75e-03 | 17 | 98 | 2 | 536 | |
| GeneFamily | Cadherin related | 3.75e-03 | 17 | 98 | 2 | 24 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | COL6A1 SPRY1 PDE8A PPP1R12A GGT1 ITIH5 PTPRK PDE8B DOCK6 TNS1 | 2.88e-06 | 303 | 130 | 10 | M39040 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.37e-06 | 180 | 130 | 8 | M8239 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | ZSWIM5 FAT3 ARFGEF2 FRYL RTN1 FREM2 AKAP9 ARVCF NUP210 CEP295 CDH1 RASAL2 | 4.54e-05 | 498 | 127 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | FAT4 TMEM169 ZSWIM5 PPP1R12A FAT3 CFTR PCDHB13 PCDHB12 PCDHB11 ARFGEF2 RTN1 | 5.26e-05 | 427 | 127 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 6.40e-05 | 166 | 127 | 7 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SPRY1 PDE8A ZSWIM5 FAT3 CHD8 FRYL FANCM RTN1 NLGN3 THRA AKAP9 ARVCF PDE8B NUP210 PPIP5K1 CDH1 RASAL2 | 8.20e-05 | 986 | 127 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 8.92e-05 | 175 | 127 | 7 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 1.30e-07 | 196 | 132 | 8 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-06 | 180 | 132 | 7 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-06 | 193 | 132 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.86e-06 | 194 | 132 | 7 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.06e-06 | 197 | 132 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.13e-06 | 198 | 132 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.28e-06 | 200 | 132 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-05 | 166 | 132 | 6 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.39e-05 | 175 | 132 | 6 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 182 | 132 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.84e-05 | 184 | 132 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.90e-05 | 185 | 132 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 186 | 132 | 6 | 10edc3dd96181b6f7bd07a5ad0862ba9fa6a9cb9 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 186 | 132 | 6 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.02e-05 | 187 | 132 | 6 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.02e-05 | 187 | 132 | 6 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-05 | 188 | 132 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.14e-05 | 189 | 132 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.41e-05 | 193 | 132 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.48e-05 | 194 | 132 | 6 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.55e-05 | 195 | 132 | 6 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.70e-05 | 197 | 132 | 6 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.78e-05 | 198 | 132 | 6 | 60d8d3bbd754ffde41c50013d822667b185a9751 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-05 | 199 | 132 | 6 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-05 | 199 | 132 | 6 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 200 | 132 | 6 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 2.94e-05 | 200 | 132 | 6 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 2.94e-05 | 200 | 132 | 6 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.94e-05 | 200 | 132 | 6 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 154 | 132 | 5 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 9.60e-05 | 154 | 132 | 5 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.60e-05 | 154 | 132 | 5 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 157 | 132 | 5 | 188d2f85babcd4eefe20e7a392d851b2e1185bab | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 160 | 132 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 160 | 132 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 161 | 132 | 5 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 162 | 132 | 5 | 9a18286e361e1dd18e6f943ce27db58b199fb6e4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 162 | 132 | 5 | 3395e4dffdb9304d157c325e1fc0f12b433c7bd3 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 162 | 132 | 5 | 9522af31f6b2f3cb81b6b84bd08353eea504d1d6 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 162 | 132 | 5 | 40265af9b36fd144a8577b8dacccd4fc0888a593 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.33e-04 | 165 | 132 | 5 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 166 | 132 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 166 | 132 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 166 | 132 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-04 | 168 | 132 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | Ionocyte|World / Class top | 1.52e-04 | 170 | 132 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-04 | 170 | 132 | 5 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 172 | 132 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-04 | 173 | 132 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-04 | 174 | 132 | 5 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.70e-04 | 174 | 132 | 5 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.70e-04 | 174 | 132 | 5 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-04 | 174 | 132 | 5 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 174 | 132 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 175 | 132 | 5 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-04 | 175 | 132 | 5 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 175 | 132 | 5 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.79e-04 | 176 | 132 | 5 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 177 | 132 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 177 | 132 | 5 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.84e-04 | 177 | 132 | 5 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 177 | 132 | 5 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-04 | 177 | 132 | 5 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.89e-04 | 178 | 132 | 5 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-04 | 179 | 132 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-04 | 180 | 132 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 180 | 132 | 5 | 5286e66ff6b7154390b3e9c189704a71d56bc89c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 180 | 132 | 5 | 2b6b295b5c21b829828afae9ab4c3eb9233f6f45 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 180 | 132 | 5 | bf587387145a2b5e83766fbccf76eecc6d5e8241 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 181 | 132 | 5 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 181 | 132 | 5 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-04 | 181 | 132 | 5 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 181 | 132 | 5 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 181 | 132 | 5 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 181 | 132 | 5 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 181 | 132 | 5 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 181 | 132 | 5 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 181 | 132 | 5 | 0069e8308de932df43660bbe926637c57b8bf7f6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 181 | 132 | 5 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.04e-04 | 181 | 132 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 182 | 132 | 5 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.15e-04 | 183 | 132 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 2.15e-04 | 183 | 132 | 5 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.15e-04 | 183 | 132 | 5 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Memory_B_cells|blood / Manually curated celltypes from each tissue | 2.15e-04 | 183 | 132 | 5 | e3a418b745d7f040adf47be9e1043b945cae47ed | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.94e-06 | 196 | 130 | 9 | 3351_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 2.02e-06 | 197 | 130 | 9 | 1678_UP | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 6519_DN | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 4796_DN | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 3898_DN | |
| Drug | Cortisone [53-06-5]; Up 200; 11uM; HL60; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 2385_UP | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Up 200; 11.6uM; HL60; HG-U133A | 1.86e-05 | 198 | 130 | 8 | 1592_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 5768_DN | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 4794_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.93e-05 | 199 | 130 | 8 | 1817_DN | |
| Drug | Levothyroxine | 3.24e-05 | 2 | 130 | 2 | DB00451 | |
| Drug | Liothyronine | 3.24e-05 | 2 | 130 | 2 | DB00279 | |
| Drug | Liotrix | 3.24e-05 | 2 | 130 | 2 | DB01583 | |
| Drug | 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid | 3.24e-05 | 2 | 130 | 2 | DB03176 | |
| Drug | KB 130015 | 3.24e-05 | 2 | 130 | 2 | ctd:C446946 | |
| Drug | Rafoxanide | 3.24e-05 | 2 | 130 | 2 | ctd:D011888 | |
| Disease | coronary artery disease | DAB2IP FAT4 PPP1R12B CFTR ARFGEF2 TMOD4 RNF213 APOA4 F13A1 PPP2R1B THADA ARVCF NUP210 TNKS DOCK6 PLEKHA7 TNS1 | 1.09e-05 | 1194 | 124 | 17 | EFO_0001645 |
| Disease | cortical thickness | PDE8A ARRDC4 FAT3 PCDHB11 ARFGEF2 ITIH5 ENO4 ZBTB34 THADA CBY2 PI4KA SSH2 PLEC PLEKHA7 TNS1 CLUH | 1.79e-05 | 1113 | 124 | 16 | EFO_0004840 |
| Disease | thyroid hormone resistance syndrome (implicated_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:11633 (implicated_via_orthology) | |
| Disease | major depressive disorder (biomarker_via_orthology) | 5.24e-05 | 3 | 124 | 2 | DOID:1470 (biomarker_via_orthology) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 5.24e-05 | 3 | 124 | 2 | C1842563 | |
| Disease | diabetic retinopathy (is_marker_for) | 7.99e-05 | 54 | 124 | 4 | DOID:8947 (is_marker_for) | |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 1.05e-04 | 4 | 124 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Generalized Thyroid Hormone Resistance | 1.05e-04 | 4 | 124 | 2 | C4722330 | |
| Disease | neuroimaging measurement | PDE8A ARRDC4 FAT3 FRYL ARMC9 PLXNB2 ITIH5 ENO4 THADA SSH2 ARHGAP27 PLEC PLEKHA7 TNS1 | 1.65e-04 | 1069 | 124 | 14 | EFO_0004346 |
| Disease | cardiovascular disease biomarker measurement, ankle brachial index | 1.74e-04 | 5 | 124 | 2 | EFO_0003912, EFO_0005278 | |
| Disease | Carcinoma, Lobular | 2.60e-04 | 6 | 124 | 2 | C0206692 | |
| Disease | cervix uteri carcinoma in situ (is_implicated_in) | 3.63e-04 | 7 | 124 | 2 | DOID:8991 (is_implicated_in) | |
| Disease | cortical surface area measurement | SPRY1 PDE8A ARRDC4 FAT3 PPP1R12B FRYL PLXNB2 ITIH5 THADA TNKS SSH2 ARHGAP27 PLEKHA7 TNS1 KDM1A | 5.32e-04 | 1345 | 124 | 15 | EFO_0010736 |
| Disease | Diaphragmatic Hernia | 6.87e-04 | 41 | 124 | 3 | C0019284 | |
| Disease | Macrocephaly | 9.40e-04 | 11 | 124 | 2 | C0221355 | |
| Disease | Congenital long QT syndrome | 9.40e-04 | 11 | 124 | 2 | cv:C1141890 | |
| Disease | Long QT syndrome | 1.12e-03 | 12 | 124 | 2 | cv:C0023976 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.16e-03 | 49 | 124 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | nodular sclerosis Hodgkin lymphoma | 1.54e-03 | 14 | 124 | 2 | EFO_0004708 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 1.98e-03 | 59 | 124 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | 5-oxoproline measurement | 2.02e-03 | 16 | 124 | 2 | EFO_0010988 | |
| Disease | Romano-Ward Syndrome | 2.02e-03 | 16 | 124 | 2 | C0035828 | |
| Disease | brain measurement, neuroimaging measurement | 2.31e-03 | 550 | 124 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.39e-03 | 63 | 124 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.10e-03 | 69 | 124 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | lung cancer (is_implicated_in) | 3.78e-03 | 74 | 124 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Bronchiectasis | 3.83e-03 | 22 | 124 | 2 | C0006267 | |
| Disease | Sarcosine measurement | 4.18e-03 | 23 | 124 | 2 | EFO_0021668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VERTRSELLPFLTDT | 56 | P30154 | |
| DPDRALTDYITRLEA | 3871 | Q99996 | |
| EPITEERASRTLYRI | 1876 | Q9HCK8 | |
| RLELSDIYQIPSVDS | 31 | P13569 | |
| PEVVRLYLSLLTESR | 661 | O00192 | |
| LDRERIPSYNLTVSV | 426 | Q6V0I7 | |
| VSERPRVLQEYTSDD | 1301 | Q9Y6D5 | |
| YSIITPNILRLESEE | 26 | P01024 | |
| LDRPSYVASEESRIL | 36 | Q9NWX5 | |
| LETLPRDVSRLAYTQ | 481 | O60826 | |
| EPERDYLEAAIRTVI | 326 | O43143 | |
| SEVEYLNVRLSLREP | 86 | Q8NCT1 | |
| DDLYRISELDRTQIP | 136 | Q6ZTQ3 | |
| VDITPYLDQLDESLR | 566 | Q68E01 | |
| EEQRVLIYESRLPDS | 136 | Q9UN73 | |
| DYVPIATDRTRLLAE | 31 | P48544 | |
| VEELRRSLAPYAQDT | 216 | P06727 | |
| IVSTTRELYLEDSPL | 121 | Q8TEM1 | |
| EYPDDRTARTLTLIA | 541 | Q5VWQ8 | |
| YTLLTERPLDRESRA | 401 | Q9Y5F0 | |
| IDPERYRLCRQEITS | 736 | Q15058 | |
| SDRPAYVTILSLVRD | 571 | Q6P4R8 | |
| DEIRTPLLSDIRIDY | 476 | Q86UX2 | |
| TRSESELLFLPDYLV | 171 | Q8WWW8 | |
| VYPEGTLELRRVTAE | 476 | O75325 | |
| LYSILSVPSIREEAR | 526 | Q7Z3E5 | |
| RTSTIPEELGRLVYL | 451 | O43861 | |
| QIELRSEDSPDILTY | 266 | Q8IYD8 | |
| LDTDDRELRYTVTQP | 731 | Q5SZK8 | |
| LARPLRTSEEPYTET | 561 | Q86YR7 | |
| RVEYDTRVSDVPLSL | 1186 | O15031 | |
| VLHRDYDRTVTLLSP | 1021 | O95206 | |
| DRVLEILRTTELYSP | 416 | O60658 | |
| DRVLEILRTTELYSP | 476 | O95263 | |
| TDRLVITPLTDRCYI | 1816 | Q96JB1 | |
| LSEELARAYPELTLA | 1271 | O94915 | |
| DSLLYVDTDILFLRP | 211 | Q4G148 | |
| VTLLSDVAYRDPSLR | 136 | P42356 | |
| QEYPDDRTSRTLTLI | 496 | Q9UJF2 | |
| SVDILLEYRSSENPV | 296 | P00488 | |
| IVASDLEPRELSSYV | 491 | Q9Y5G1 | |
| DRETVPEYNLSITAR | 416 | Q9UN70 | |
| DRVLDVVERSLSNYP | 146 | P49961 | |
| LSSYPRLREETERIV | 446 | P50570 | |
| IPLLADVTRRLSEDY | 101 | P32119 | |
| YTLETERPLDRESRA | 401 | Q9Y5F1 | |
| PLVDLSYDSALEVLR | 71 | P29475 | |
| YTLETERPLDRESTA | 401 | Q9Y5F2 | |
| ERPLDRESTAEYNIT | 406 | Q9Y5F2 | |
| RLEPIRYSVLEETES | 26 | Q9Y5E5 | |
| RPLDRETSAEYNITI | 406 | Q9Y5E5 | |
| LLVENPRDYSTELSV | 696 | Q9NZ94 | |
| YTRKRDTRSESLEIP | 31 | Q8NA61 | |
| ESSPDRRLTLSQIYE | 256 | A0A2Z4LIS9 | |
| ADYIPTVEDILRSRD | 166 | P19086 | |
| PSDVYLSSRDRQILD | 516 | O60341 | |
| VAELYLPLLSIARDT | 1161 | Q96HP0 | |
| LEPRLSIIATDHTYR | 196 | P12109 | |
| YRELPAEVRETLGSL | 911 | O75460 | |
| QRSLTAEYEIPSVRE | 161 | Q96LA6 | |
| RGPDALTLLEYTETR | 336 | Q96JB5 | |
| IETLERYLADLPTLE | 476 | Q6P2H3 | |
| ERPSEYIATILELSA | 216 | Q9HCS2 | |
| FERRDYLVTVPEDTS | 3236 | Q8TDW7 | |
| TALSEYRPILSQEHR | 201 | Q5UAW9 | |
| VLFRSISERDPYLVS | 516 | Q9Y2G2 | |
| LPTEYERSLITRFER | 756 | O95466 | |
| DVPRRLEELLNSTFY | 31 | A6NNW6 | |
| LEYDPTQRITLDEAL | 456 | Q9HAZ1 | |
| LVLQTRPESSDLYSE | 866 | Q9Y613 | |
| YEDRDPLRVSISREQ | 1871 | Q9C0D2 | |
| LYTLLSQERRADPEA | 316 | P51530 | |
| EPIYESLLRASIENS | 221 | Q8N815 | |
| LTPATALDLVRRYDV | 161 | O95396 | |
| VTEPLDRERIATYTL | 216 | P12830 | |
| DRLVITPLTDRCYIT | 1951 | Q8TE73 | |
| DTEYEIRVLLTRPGE | 356 | Q15262 | |
| STDTRLRPDQRYLEE | 756 | Q9BZF2 | |
| LTSDNVIRIYSLREP | 191 | Q99567 | |
| LRDPSERVLSDYTQV | 146 | O14792 | |
| SPSIQYSILREEREA | 446 | Q16799 | |
| DSYAESRQLTLPRTE | 1936 | Q6YHU6 | |
| TSELALELIDRYEPS | 241 | Q9BRC7 | |
| VASERELYIPSVDLL | 541 | Q14596 | |
| RAVELDSESRYPQAL | 21 | Q8WV92 | |
| TNTRITDPEILESRY | 1141 | O14841 | |
| TRELIARRTTPLLEY | 206 | Q9H1J1 | |
| LTDYRAELRDDPIIS | 306 | O00231 | |
| RPLARSDSENVYEVI | 191 | Q6ZUM4 | |
| DSRVELRSYVSEPEL | 976 | Q6IQ23 | |
| LYEETRSHIPLLSEL | 186 | P0DUX0 | |
| LYEETRSHIPLLSEL | 186 | P0DTA3 | |
| LYEETRSHIPLLSEL | 186 | P0DUD1 | |
| LREIPSVVYRLDSLT | 181 | Q9UQ13 | |
| EAITYREVLESGPLR | 21 | O60902 | |
| DLLSRYRLEVPESVT | 146 | Q96PQ1 | |
| LSRPEISTDERAYQR | 856 | O94855 | |
| LDVVLDSSARVAPYR | 46 | Q66K14 | |
| VVSHPRYLELLERTS | 511 | O75153 | |
| YFSTLDIQLRESLEP | 761 | Q96EP0 | |
| ISYEVERDLTPLILS | 4921 | Q63HN8 | |
| TTILRLSLDYPQREE | 931 | Q9P217 | |
| RLDPDTAYSRLIVSE | 306 | Q6AZZ1 | |
| PDFSEYRRLEVLDST | 86 | P47985 | |
| VDPYELASLRERNIT | 91 | Q8TBF5 | |
| TLYEQVSERLRTLPA | 1376 | Q99973 | |
| PADDELYQRTRISLL | 36 | Q9BU61 | |
| PEDNIRLAVRLESTY | 86 | Q76I76 | |
| LLVSRPDEENITSYL | 486 | Q5PRF9 | |
| DDYLAQLSLEPTTRT | 391 | Q12816 | |
| YPQTRLRLEEALSEA | 591 | Q96PX9 | |
| LYEETRSHIPLLSEL | 186 | A0A494C0Z2 | |
| LYEETRSHIPLLSEL | 186 | P0DUD3 | |
| LYEETRSHIPLLSEL | 186 | P0DUD4 | |
| LYEETRSHIPLLSEL | 186 | P0DUD2 | |
| ESTPIRTSDVDYRLL | 641 | O95271 | |
| RAAVRYDPESETLTL | 316 | P10828 | |
| VRLSEEPRSYVESVA | 1016 | Q9HBL0 | |
| DVVLDSSARVAPYRI | 51 | Q6ZT07 | |
| RLDYEREIQPTAILS | 26 | O43609 | |
| DRLRSDYTTLLCEIP | 2041 | Q86WI1 | |
| RPELEDSTLRYLQDL | 651 | Q15149 | |
| YRDIDEDEILRTLSP | 11 | Q9NZQ9 | |
| ESYPRRTIIIEDNRS | 231 | Q9BVV7 | |
| LYEETRSHIPLLSEL | 186 | A0A494C191 | |
| LRAAVRYDPESDTLT | 261 | P10827 | |
| ESRPESIIIYRSDNE | 46 | Q96HH4 | |
| SLRTLREYVAVEPLA | 871 | O14939 | |
| RTTVRLESTLYLPEL | 166 | Q9BZD7 | |
| LRYLQEARSREPTDT | 191 | Q8N6N2 | |
| PRSVDLQLYHSETLE | 696 | Q6PFW1 | |
| EVRSRIESPERTDVY | 456 | Q8NCN2 | |
| ERLTLPQLADTYETL | 206 | P19440 | |
| LEPLFDSYTSELRRQ | 196 | O95678 | |
| DVARRYPEVTSLSLE | 216 | Q8N9H8 | |
| SREDPVSTELIYRQV | 1296 | Q6PIF6 | |
| RRSYLTPVRDEESES | 666 | O14974 | |
| RRSYLTPVRDEEAES | 616 | O60237 |